The PE Ratio as of September 2024 (TTM) for Clearmind Medicine Inc. (CMND) is 0.17

According to Clearmind Medicine Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 0.17. This represents a change of -120.10% compared to the average of -0.85 of the last 4 quarters.

Clearmind Medicine Inc. (CMND) Historical PE Ratio (quarterly & annually)

How has CMND PE Ratio performed in the past?

The mean historical PE Ratio of Clearmind Medicine Inc. over the last ten years is -0.29. The current 0.17 PE Ratio has changed -5991.15% with respect to the historical average. Over the past ten years (40 quarters), CMND's PE Ratio was at its highest in in the July 2022 quarter at -0.00. The PE Ratio was at its lowest in in the July 2023 quarter at -1.81.

Clearmind Medicine Inc. (CMND) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Clearmind Medicine Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Clearmind Medicine Inc. (CMND) Average PE Ratio

How has CMND PE Ratio performed in the past?

The current PE Ratio of Clearmind Medicine Inc. (CMND) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Clearmind Medicine Inc. (CMND) PE Ratio vs. Peers

How is CMND’s PE Ratio compared to its peers?

Clearmind Medicine Inc.’s PE Ratio is greater than Hillstream BioPharma, Inc. (-0.00), greater than Coeptis Therapeutics, Inc. (-0.45), greater than Magenta Therapeutics, Inc. (-0.04), greater than Quoin Pharmaceuticals, Ltd. (-0.34), greater than Cardio Diagnostics Holdings, Inc. (-0.75), greater than Windtree Therapeutics, Inc. (-0.16), greater than NovaBay Pharmaceuticals, Inc. (-0.05), greater than Baudax Bio, Inc. (-0.21), greater than Revelation Biosciences, Inc. (-0.09), greater than Blue Water Vaccines, Inc. (-0.17), greater than PaxMedica, Inc. Common Stock (-0.00), greater than Unicycive Therapeutics, Inc. (-0.54), greater than Virax Biolabs Group Limited (-0.98), greater than Immix Biopharma, Inc. (-2.77), greater than CNS Pharmaceuticals, Inc. (-0.00), greater than eFFECTOR Therapeutics, Inc. (-0.01), greater than Navidea Biopharmaceuticals, Inc. (0.03), greater than Sonnet BioTherapeutics Holdings, Inc. (-0.66),

Build a custom stock screener for Clearmind Medicine Inc. (CMND) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clearmind Medicine Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clearmind Medicine Inc. (CMND) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clearmind Medicine Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.